XML 72 R57.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Share-based Compensation [Abstract]    
Maximum number of shares of common stock that may be issued (in shares) 4,000,000  
Expense incurred $ 1,821 $ 1,457
Income tax benefits of share-based compensation 155 84
Share-based compensation cost capitalized 0 0
Cost of Goods Sold [Member]    
Share-based Compensation [Abstract]    
Expense incurred 281 143
Selling, General and Administrative [Member]    
Share-based Compensation [Abstract]    
Expense incurred 1,378 1,180
Research and Development [Member]    
Share-based Compensation [Abstract]    
Expense incurred 162 134
Restricted Stock [Member]    
Share-based Compensation [Abstract]    
Expense incurred $ 1,764 $ 1,367
Restricted Stock [Abstract]    
Number of shares granted in period (in shares) 786,500 535,400
Weighted-average grant-date fair value of awards (in dollars per share) $ 16.77 $ 19.28
Shares outstanding at balance sheet date (in shares) 1,374,422 1,128,179
Estimated Expenses Not Yet Incurred [Abstract]    
Compensation cost not yet recognized $ 18,526 $ 15,106
Weighted-average amortization period for cost not yet recognized (in years) 3 years 2 months 12 days 3 years
Restricted Stock [Member] | Minimum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 1 year  
Restricted Stock [Member] | Maximum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 4 years  
Stock Options [Member]    
Share-based Compensation [Abstract]    
Expense incurred $ 1 $ 38
Stock options activity [Abstract]    
Contractual term 10 years  
Number of options granted in period (in shares) 0 0
Cash received from option exercised $ 563 $ 3,714
Estimated Expenses Not Yet Incurred [Abstract]    
Compensation cost not yet recognized $ 0 $ 71
Weighted-average amortization period for cost not yet recognized (in years)   1 year
Outstanding and exercisable option awards [Roll Forward]    
Outstanding at end of period (in shares) 528,551  
Exercisable at end of period (in shares) 528,551  
Weighted-Average Exercise Price [Abstract]    
Outstanding at end of period (in dollars per share) $ 10.11  
Exercisable at end of period (in dollars per share) $ 10.11  
Weighted-Average Remaining Contractual Life (in years) [Abstract]    
Outstanding at end of period 3 years 3 months 10 days  
Exercisable at end of period 3 years 3 months 10 days  
Aggregate Intrinsic Value [Abstract]    
Outstanding at end of period $ 4,605  
Exercisable at end of period $ 4,605  
Stock Options [Member] | Minimum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 1 year  
Stock Options [Member] | Maximum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 4 years  
Employee Stock Purchase Plan [Member]    
Share-based Compensation [Abstract]    
Expense incurred $ 56 $ 52